Therefore, we deleted the regional and distant metastases patients, leaving the localized ccRCC patients for further analysis of POLD1 expression as an additional independent outcome variable with utility compared with traditional clinicopathologic variables (Supplementary Figure S2). This evidence concerns the gene POLD1 and nonpapillary renal cell carcinoma.